BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Prognosis
34 results:

  • 1. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
    JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
    Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
    Tan S; Chao R
    Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrative radiomics and transcriptomics analyses reveal subtype characterization of non-small cell lung cancer.
    Lin P; Lin YQ; Gao RZ; Wan WJ; He Y; Yang H
    Eur Radiol; 2023 Sep; 33(9):6414-6425. PubMed ID: 36826501
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.
    Zhang X; Chen Q; He Y; Shi Q; Yin C; Xie Y; Yu H; Bao Y; Wang X; Tang C; Dong Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):19. PubMed ID: 36639675
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
    Xu F; Cui WQ; Liu C; Feng F; Liu R; Zhang J; Sun CG
    FEBS Open Bio; 2023 Jan; 13(1):72-88. PubMed ID: 36282125
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patients deriving long-term benefit from immune checkpoint inhibitors demonstrate conserved patterns of site-specific mutations.
    Principe DR
    Sci Rep; 2022 Jul; 12(1):11490. PubMed ID: 35798829
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of Breast cancer.
    Kopanja D; Chand V; O'Brien E; Mukhopadhyay NK; Zappia MP; Islam ABMMK; Frolov MV; Merrill BJ; Raychaudhuri P
    Cancer Res; 2022 Jul; 82(13):2458-2471. PubMed ID: 35583996
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Machine Learning Identifies Pan-cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes.
    Li N; Zhan X
    Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of bromodomain-containing protein 4 (BRD4) and intestine-specific homeobox (ISX) expression on the prognosis of patients with hepatocellular carcinoma' for better clarity.
    Chuang KT; Wang SN; Hsu SH; Wang LT
    Cancer Med; 2021 Aug; 10(16):5545-5556. PubMed ID: 34173348
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Primary lung cancer and occupational exposure in a North African population].
    Ketfi A; Zanoun N; Laouedj I; Gharnaout M; Fraga S
    Pan Afr Med J; 2020; 37():120. PubMed ID: 33425153
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
    Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
    Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Analysis of the feasibility and prognostic value of circulating tumor DNA in detecting gene mutations in small cell lung cancer].
    Jin Y; Chen YM; Hu X; Tang HR; Yu XM; Fan Y; Xu YJ; Xu HM; Li PS; Li Q; Chang LP; Guan YF; Chen M
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(45):3614-3621. PubMed ID: 33333686
    [No Abstract]    [Full Text] [Related]  

  • 13. Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion.
    Watermann C; Pasternack H; Idel C; Ribbat-Idel J; Brägelmann J; Kuppler P; Offermann A; Jonigk D; Kühnel MP; Schröck A; Dreyer E; Rosero C; Nathansen J; Dubrovska A; Tharun L; Kirfel J; Wollenberg B; Perner S; Krupar R
    Clin Cancer Res; 2021 Jan; 27(2):632-644. PubMed ID: 33109740
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution model.
    Kunimasa K; Hirotsu Y; Nakamura H; Tamiya M; Iijima Y; Ishida H; Hamamoto Y; Maniwa T; Kimura T; Nishino K; Goto T; Amemiya K; Mochizuki H; Oyama T; Nakatsuka SI; Kumagai T; Okami J; Higashiyama M; Imamura F; Omata M
    Cancer Genet; 2020 Feb; 241():51-56. PubMed ID: 31917104
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PCAF-mediated acetylation of ISX recruits BRD4 to promote epithelial-mesenchymal transition.
    Wang LT; Liu KY; Jeng WY; Chiang CM; Chai CY; Chiou SS; Huang MS; Yokoyama KK; Wang SN; Huang SK; Hsu SH
    EMBO Rep; 2020 Feb; 21(2):e48795. PubMed ID: 31908141
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer.
    Zhou M; Fan J; Li Z; Li P; Sun Y; Yang Y; Zhou X; Wang J; Wang Y; Qi H; Cai W; Dai X; Hirsch FR
    Respir Res; 2019 Nov; 20(1):248. PubMed ID: 31699089
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/cbp signaling pathway.
    Cui Y; Wu X; Lin C; Zhang X; Ye L; Ren L; Chen M; Yang M; Li Y; Li M; Li J; Guan J; Song L
    Oncogene; 2019 Jul; 38(27):5516-5529. PubMed ID: 30936461
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.
    Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
    Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic effect of factors involved in revised Tokuhashi score system for patients with spinal metastases: a systematic review and Meta-analysis.
    Yang XG; Lun DX; Hu YC; Liu YH; Wang F; Feng JT; Hua KC; Yang L; Zhang H; Xu MY; Zhang HR
    BMC Cancer; 2018 Dec; 18(1):1248. PubMed ID: 30545326
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis.
    Zhang H; Wang Y; Dou J; Guo Y; He J; Li L; Liu X; Chen R; Deng R; Huang J; Xie R; Zhao X; Yu J
    Oncogene; 2019 Feb; 38(9):1410-1431. PubMed ID: 30305728
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.